Scholay

学术搜索 · AI 审稿 · LaTeX 协作

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

作者:Caicun Zhou, Yanping Hu, Ekaterine Arkania, Saadettin Kılıçkap, Kejing Ying, Fei Xu, Lin Wu, Xiang Wang, Maksym Viguro, Tamta Makharadze, Hongmei Sun, Feng Luo, Jianhua Shi, Aimin Zang, Yueyin Pan, Zhendong Chen, Zhongyao Jia, Vladimer Kuchava, Ping Lu, Ling Zhang, Ying Cheng, Wenying Kang, Qingyu Wang, Haoyu Yu, Jing Li, Junwu Zhu · 发表于:Cancer Cell · 年份:2024 · DOI:10.1016/j.ccell.2023.12.004 · 被引用次数:66 · 研究领域:Lung Cancer Treatments and Mutations、Cancer Immunotherapy and Biomarkers、Colorectal and Anal Carcinomas